What is lecanemab and how does it slow down Alzheimer's disease?

What is lecanemab and how does it slow down Alzheimer's disease?

  • Höfundur
  • Episode
      259
  • Published
      6 nov. 2025
  • Útgefandi
0 Umsagnir
0
Episode
259 of 261
Lengd
27Mín.
Tungumál
enska
Gerð
Flokkur
Sjálfsrækt

A new Health Canada-approved drug called lecanemab has been shown to slow early-stage Alzheimer's disease. Neurologist Dr. Sharon Cohen, who participated in phase three trials for the drug, explains why lecanemab is such a big deal.

For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.


Hlustaðu og lestu

Stígðu inn í heim af óteljandi sögum

  • Lestu og hlustaðu eins mikið og þú vilt
  • Þúsundir titla
  • Getur sagt upp hvenær sem er
  • Engin skuldbinding
is Device Banner Block 894x1036
Cover for What is lecanemab and how does it slow down Alzheimer's disease?

Other podcasts you might like ...